Showing results (81-90 of 347) with videos related to
Sort By:
Pageof 35
Alcohol Research & Health : the Journal of the National Institute on Alcohol Abuse and Alcoholism|April 13, 2013
Focus on: Alcohol and the immune systemPatricia E Molina, Kyle I Happel, Ping Zhang, et al.Infection and Immunity|August 17, 2002
Increased host resistance against Pneumocystis carinii pneumonia in gammadelta T-cell-deficient mice: protective role of gamma interferon and CD8(+) T cellsChad Steele, Mingquan Zheng, Erana Young, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2003
Transient increase in lung epithelial tight junction permeability: an additional mechanism for enhancement of lung transgene expression by perfluorochemical liquidsDaniel J Weiss, Travis Beckett, Laura Bonneau, et al.Frontiers in Bioscience : a Journal and Virtual Library|May 8, 2002
Ethanol and LPS modulate NF-kappaB activation, inducible NO synthase and COX-2 gene expression in rat liver cells in vivoJudy A Spitzer, Mingquan Zheng, Jay K Kolls, et al.Plos One|December 11, 2013
A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severityKevin J McHugh, Sivanarayana Mandalapu, Jay K Kolls, et al.Respiratory Research|October 26, 2005
Alcohol reversibly disrupts TNF-alpha/TACE interactions in the cell membraneKejing Song, Xue-Jun Zhao, Luis Marrero, et al.Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Chemokines orchestrate leukocyte trafficking in inflammatory bowel diseaseWenwei Zhong, Jay K Kolls, Hong Chen, et al.Alcoholism, Clinical and Experimental Research|September 15, 2004
Chronic ethanol enhances ectodomain shedding in T cells and monocytesXue-Jun Zhao, Peter Oliver, Kejing Song, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2009
IL-23 is required for protection against systemic infection with Listeria monocytogenesKaren D Meeks, Amy N Sieve, Jay K Kolls, et al.International Immunopharmacology|February 27, 2007
After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?Zili Zhang, David J Hinrichs, Huiying Lu, et al.Pageof 35